Meet the leadership team behind
Aspira Women's Health

Executive Leadership Team

  • 'photograph of Valerie Palmieri

    Valerie Palmieri

    President and CEO

  • 'photograph of Robert Beechey

    Robert Beechey

    Chief Financial Officer

  • 'photograph of Kaile Zagger

    Kaile Zagger

    Chief Operating Officer

  • 'photograph of Lesley Northrop

    Lesley Northrop, Ph.D., DABMGG, FACMG

    Chief Scientific Officer

  • 'photograph of Elena Ratner

    Elena Ratner, M.D.

    Global Chief Medical Advisor, Clinical and Translational Medicine

  • 'photograph of Greg Richard

    Greg Richard

    Head of Corporate Strategy, Reimbursement and Managed Care

Senior Leadership Team

  • 'photograph of Gary Altwerger

    Gary Altwerger, M.D.

    Global Deputy Chief Medical Advisor, Clinical and Translational Medicine

  • 'photograph of Tatiana Black

    Tatiana Black, RPh.

    Senior Director of Regulatory Affairs and Quality Assurance, Compliance Officer

  • 'photograph of Patrick Carpenter

    Patrick Carpenter

    General Manager, Aspira Labs

  • 'photograph of Justin DeGrazia

    Justin DeGrazia

    Senior Director of Research & Development

  • 'photograph of Herbert A. Fritsche, Jr.

    Herbert A. Fritsche, Jr., Ph.D.

    Lab Director, Aspira Labs

  • 'photograph of Shieva Ghofrany, MD FACOG

    Shieva Ghofrany, MD FACOG

    Head of Global Clinical Implementation

  • 'photograph of Emily Granger

    Emily Granger

    Senior Director of Marketing

  • 'photograph of Tom Greco

    Tom Greco

    Head of Strategic Corporate Development and Expansion

  • 'photograph of Kimberly Greene

    Kimberly Greene

    Vice President, Strategic Partnerships

  • 'photograph of Jessica Greenwood

    Jessica Greenwood, MS, CGC

    Senior Director, Clinical Implementation and Innovation

  • 'photograph of Albert Johnson

    Albert Johnson

    West Zone Sales Leader

  • 'photograph of Cathy Minton

    Cathy Minton

    Senior Director of Revenue Cycle Management

  • 'photograph of Nick Piergallini

    Nick Piergallini

    East Zone Sales Leader

  • 'photograph of Diane Powis

    Diane Powis, Ph.D.

    Chief Spokeswoman

  • 'photograph of April J.L. Pradier

    April J.L. Pradier

    Director of Program Management

  • 'photograph of Loreli Quintero-Jolliff

    Loreli Quintero-Jolliff

    Enterprise Business Activation Director

  • 'photograph of Ahmad Saleh

    Ahmad Saleh

    Head of Hospital Systems

  • 'photograph of Stephanie Swenson

    Stephanie Swenson


Board of Directors

James T. LaFrance

Chairman of the Board, Aspira Women's Health

James T. LaFrance became a director of Aspira Women's Health and was elected Chairman of the Board in December 2013. He served as President and Chief Executive Officer from April to December 2014. He has over thirty years of diagnostic industry experience. Most recently, LaFrance was head of digital pathology and CEO of Omnyx, LLC for GE Healthcare. Prior to that, he held a series of commercial, strategic marketing and business development leadership roles at Ventana Medical Systems (now Roche Tissue Diagnostics), including general manager of their North American and International commercial organizations. Prior to Ventana, LaFrance served in leadership roles in global marketing and business development at Bayer Diagnostics. Jim currently serves on the board of HTG Molecular in Tucson and Personal Genome Diagnostics in Baltimore. Jim is also on the Advisory Board of PathAi in Boston. He earned a Bachelor of Arts degree in economics from the University of Connecticut and an MBA from the University of Notre Dame.

Veronica G. H. Jordan, Ph.D.

Dr. Veronica G. H. Jordan became a director of Aspira Women's Health in December 2014. She currently serves as an advisor to companies developing novel healthcare products and services. Previously, from 2001-2006, she was President and CEO of Medelle Corporation, a medical device company in women’s health. Prior to that, Dr. Jordan served for fourteen years in various executive positions at PAREXEL International Corporation. Earlier, she held business leadership roles at Biogen and managed an R&D department for Baxter International. Dr. Jordan currently serves on the board of Albany Molecular Research Inc. as well as a number of not-for-profit organizations working to advance healthcare initiatives. She earned a B.Sc. in biochemistry from Cambridge University and a Ph.D. in biochemistry/cell biology from Oxford University.

Valerie B. Palmieri

President and Chief Executive Officer, Aspira Women's Health

David Schreiber

David Schreiber became a director of Aspira Women's Health in December 2014. He has held a variety of executive positions in the diagnostic laboratory industry for the past 25 years. For the last 12 years, Schreiber has and continues to consult for private equity firms to assist with their due diligence efforts and served in various interim operating roles for targeted or existing portfolio companies. From 1986 to 1996, Schreiber was at Quest Diagnostics, initially in a variety of financial roles, his last position being Vice President and General Manager of Quest’s Midwest Region, based in Chicago, Illinois. Following Quest, from 1996 to 2003, Schreiber was Senior Vice President and Chief Financial Officer of Dianon Systems, a publicly-traded specialized pathology company, until Dianon was acquired by LabCorp. Schreiber was also a member of Dianon’s Board of Directors. Following Dianon, Schreiber joined the Board of Directors of Specialty Labs, a publicly-traded lab company focused on serving the esoteric needs of hospitals. Schreiber helped lead the turnaround of Specialty Labs which led to its successful sale to Ameripath/Welsh Carson. At the same time, Schreiber joined and served on the Board of Nanogen, a publicly-traded nanotechnology company and also began his consulting career. Mr. Schreiber received his B.S. in finance with a minor in economics in 1982 and holds an MBA from Northern Illinois University in 1984.

Sandra E. Brooks, MD, MBA

Dr. Brooks was appointed to the Board of Directors in November 2020. Dr. Brooks is Senior Vice President & Chief Medical Officer at Thomas Jefferson University Hospitals, Center City Division, and a Professor in the Department of Obstetrics and Gynecology, Sidney Kimmel Medical College. Dr. Brooks trained in Obstetrics and Gynecology at the Hospital of the University of Pennsylvania and in Gynecologic Oncology at the Brigham and Women’s Hospital, Harvard Medical School, Dr. Brooks also served as Professor and Director of the Division of Gynecology Oncology at the University of Maryland for 10 years where in addition to clinical practice, and teaching trainees, her research focused on health services and cancer disparities. Dr. Brooks received her MBA in Medical Services Management at Johns Hopkins University before transitioning to physician executive roles in multi-site ambulatory and health system settings.

Nicole Sandford, CPA

Ms. Nicole Sandford, CPA was appointed to the Board of Directors in February 2021. Ms. Sandford is a seasoned professional and qualified audit committee financial expert with extensive experience advising boards and senior executives in their most challenging times. She served global accounting and consulting firm Deloitte from 1993 to 2020, most recently as the national managing partner for its Regulatory and Operational Risk practice. As one of Deloitte’s most knowledgeable experts in corporate governance, Nicole wrote Deloitte’s response to the governance aspects of the Sarbanes-Oxley Act and was the architect of its award-winning Center for Board Effectiveness. She also served as the audit partner for complex public companies in a variety of industries. Nicole is a frequent speaker on governance, risk, and culture, as well as leading practices for boards and board committees. Nicole is passionate about helping people with cancer as a volunteer driver for the American Cancer Society’s “Road to Recovery” program and as the patient advocate/representative on the Greenwich Hospital Breast Center Accreditation Leadership Committee.